These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Effectiveness and Safety of Apixaban, Dabigatran, and Rivaroxaban Versus Warfarin in Patients With Nonvalvular Atrial Fibrillation and Previous Stroke or Transient Ischemic Attack. Coleman CI, Peacock WF, Bunz TJ, Alberts MJ. Stroke; 2017 Aug; 48(8):2142-2149. PubMed ID: 28655814 [Abstract] [Full Text] [Related]
7. Ischaemic and haemorrhagic stroke associated with non-vitamin K antagonist oral anticoagulants and warfarin use in patients with atrial fibrillation: a nationwide cohort study. Staerk L, Fosbøl EL, Lip GYH, Lamberts M, Bonde AN, Torp-Pedersen C, Ozenne B, Gerds TA, Gislason GH, Olesen JB. Eur Heart J; 2017 Mar 21; 38(12):907-915. PubMed ID: 27742807 [Abstract] [Full Text] [Related]
12. Comparisons between Oral Anticoagulants among Older Nonvalvular Atrial Fibrillation Patients. Deitelzweig S, Keshishian A, Li X, Kang A, Dhamane AD, Luo X, Balachander N, Rosenblatt L, Mardekian J, Pan X, Nadkarni A, Di Fusco M, Garcia Reeves AB, Yuce H, Lip GYH. J Am Geriatr Soc; 2019 Aug 21; 67(8):1662-1671. PubMed ID: 31112292 [Abstract] [Full Text] [Related]
17. Efficacy and safety of edoxaban in comparison with dabigatran, rivaroxaban and apixaban for stroke prevention in atrial fibrillation. An indirect comparison analysis. Skjøth F, Larsen TB, Rasmussen LH, Lip GY. Thromb Haemost; 2014 May 05; 111(5):981-8. PubMed ID: 24577485 [Abstract] [Full Text] [Related]